Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SOBR Safe, Inc. (IMLE)
|
Add to portfolio |
|
|
|
| Price: |
$2.35
| | Metrics |
| OS: |
18.5
|
M
| |
|
|
| Market cap: |
$43.6
|
M
| |
|
|
|
Net debt:
|
$2.31
|
M
| |
|
|
|
EV:
|
$45.9
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($11.5)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.4 | 0.3 |
| Revenue growth | | | | -100.0% | | -100.0% | 23.3% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.4 | 0.3 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 45.3% | | | | 0.0% | | 0.0% | 0.0% |
| Selling, general and administrative | | | | | | | | |
| Research and development | 1.4 | 1.2 | 0.6 | 0.0 | | | | |
| General and administrative | 7.6 | 3.9 | 2.0 | 0.2 | 0.3 | 0.3 | 0.4 | 0.4 |
| EBITA | -10.0 | -5.2 | -2.9 | -0.8 | -0.3 | -0.3 | -0.4 | -0.4 |
| EBITA margin | -28390.2% | | | | -100.0% | | -100.0% | -139.3% |
| Amortization of intangibles | 0.4 | 0.4 | | | | | | |
| EBIT | -10.4 | -5.6 | -2.9 | -0.8 | -0.3 | -0.3 | -0.4 | -0.4 |
| EBIT margin | -29481.5% | | | | -100.0% | | -100.0% | -139.3% |
| Pre-tax income | -12.4 | -7.9 | -30.0 | -1.3 | -0.6 | -0.6 | -0.6 | -0.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.7% | 0.7% |
| Net income | -20.9 | -7.9 | -30.0 | -1.2 | -0.6 | -0.6 | -0.6 | -0.7 |
| Net margin | -59046.4% | | | | -187.0% | | -150.2% | -215.4% |
| |
| Diluted EPS | ($1.90) | ($0.91) | ($1.95) | ($0.25) | $0.00 | ($0.01) | ($0.01) | ($0.01) |
| Shares outstanding (diluted) | 11.0 | 8.7 | 15.4 | 5.1 | 114.5 | 97.8 | 67.3 | 59.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|